Retina

New research and EURETINA highlights from the director of the "underdog" eye clinic

How retinal imaging can provide clinicians a deeper understanding of myopia

Yousif Subhi, MD, PhD, discusses his Ophthalmologica Lecture, "Things That Matter: An Evidence-Based Approach to AMD and CSC"

The CHMP will recommend SB15, biosimilar to aflibercept (Eylea), for marketing authorisation by the European Commission

Research findings from Moorfields Eye Hospital also indicate SDD and drusen differ in many factors related to stroke risk

We spoke with Andrea Govetto, MD, PhD, winner of the inaugural Ramin Tadayoni Award at EURETINA

Researchers in Portugal investigated Usher syndrome, Senior-Loker syndrome and other ciliopathies

Why having a set process for diagnostic imaging is crucial to patient outcomes

Bothnia Dystrophy generally presents during early childhood; patients have night blindness, progressive visual loss, and subsequent legal blindness.

A case series illuminates neuro-ophthalmologic manifestations, retinal vascular involvement and other pathologies

The research team used spectral-domain OCT and OCT angiography imaging to study the changes in the retinal microvasculature in patients

Dr Margaret A. Chang shares data on the port delivery system with ranibizumab, and her strategy for making the most of conferences

Spotlight on the retina specialists who make up the Eye Care Network advisory boards

Businesses in the retina care space tease new technologies and cutting-edge therapeutics

As part of the Barcelona meeting, retina specialists can recognise the awareness day early

Focus on collaboration, career development and innovation

The Ramin Tadayoni Award supports the next generation of retina researchers while paying tribute to a leader in the field

The future of the tech-forward surgical suite

A meta-analysis indicates a "significant association" between vitamin D deficiency and increased risk of RVO

Clinical associations, imaging strategies and establishing a differential diagnosis from pseudopapilloedema

Lupin has successfully completed a clinical study of LUBT010, a ranibizumab biosimilar to Lucentis

A postcard from the American Society of Retina Specialists meeting in Stockholm

In a press release, Roche noted that up to 60% of patients were able to extend treatment intervals to 3 or 4 months

The EMA issued a designation for the small molecule photoswitch, which targets inherited retinal diseases including retinitis pigmentosa

Consultant ophthalmologist Christiana Dinah, BSc, MB BS, MRes, presented research findings on retinal vein occlusion in the United Kingdom

Chase Ludwig, MD, speaks about the effect of vitrectomy on the progression of age-related macular degeneration

At this year's ASRS meeting, Patrick C. Staropoli, MD, discussed his presentation about autosomal dominant pericentral retinitis pigmentosa

Richard B. Rosen, MD, recipient of the ASRS Founders Award for 2024, discusses his presentation at the meeting

At this year's ASRS meeting, Sally S. Ong, MD, shared results from a 10-year study on socioeconomic barriers and visual outcomes

Ashkan Abbey, MD, discusses 36-month outcomes of real-world patients receiving fluocinolone acetonide 0.18 mg